These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2132173)

  • 1. Serotonin: receptors and antagonists--summary of symposium.
    Prichard BN; Smith CC
    Clin Physiol Biochem; 1990; 8 Suppl 3():120-8. PubMed ID: 2132173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin agonists and antagonists in experimental hypertension.
    Saxena PR; Bolt GR; Dhasmana KM
    J Cardiovasc Pharmacol; 1987; 10 Suppl 3():S12-8. PubMed ID: 2446059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism by methysergide of neurogenic vasoconstriction in the dog forelimb.
    Jandhyala BS; Kivlighn SD
    Fed Proc; 1987 Feb; 46(2):276-80. PubMed ID: 3100343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serotoninergic receptors and cardiovascular diseases].
    Hong E; Castillo C; Flores E; Mercedes F
    Gac Med Mex; 1994; 130(3):131-3. PubMed ID: 7657075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs.
    van Zwieten PA; Blauw GJ; van Brummelen P
    Clin Physiol Biochem; 1990; 8 Suppl 3():1-18. PubMed ID: 2132170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular effects of serotonin and ischemia.
    Vanhoutte PM
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S15-9. PubMed ID: 1369711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contractions of isolated canine coronary arteries resistant to S2-serotonergic blockade.
    Cohen RA
    J Pharmacol Exp Ther; 1986 May; 237(2):548-52. PubMed ID: 2939235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serotonin and serotonin antagonism in cardiovascular and non-cardiovascular disease.
    Frishman WH; Huberfeld S; Okin S; Wang YH; Kumar A; Shareef B
    J Clin Pharmacol; 1995 Jun; 35(6):541-72. PubMed ID: 7665716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotonin receptor binding sites: is there pharmacological and clinical significance?
    Leysen J
    Med Biol; 1983 Jun; 61(3):139-43. PubMed ID: 6314066
    [No Abstract]   [Full Text] [Related]  

  • 10. Cell proliferation in carcinoid valve disease: a mechanism for serotonin effects.
    Rajamannan NM; Caplice N; Anthikad F; Sebo TJ; Orszulak TA; Edwards WD; Tajik J; Schwartz RS
    J Heart Valve Dis; 2001 Nov; 10(6):827-31. PubMed ID: 11767194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive effects of serotonin on proximal coronary arteries in awake dogs.
    Chu A; Cobb FR
    Circ Res; 1987 Nov; 61(5 Pt 2):II81-7. PubMed ID: 3664987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
    Gershon MD
    Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotonin and cardiovascular diseases].
    Reneman RS; Wenting GJ
    Ned Tijdschr Geneeskd; 1995 Oct; 139(41):2080-4. PubMed ID: 7477565
    [No Abstract]   [Full Text] [Related]  

  • 14. Doxazosin and serotonin (5-HT) receptor (1A, 2A, and 4) antagonists inhibit 5-HT-mediated human cavernosal contraction.
    Lau DH; Thompson CS; Bellringer JF; Thomas PJ; Mumtaz FH; Morgan RJ; Mikhailidis DP
    J Androl; 2006; 27(5):679-85. PubMed ID: 16728720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 5-HT receptors mediating constriction of porcine carotid arteriovenous anastomoses; involvement of 5-HT1B/1D and novel receptors.
    De Vries P; Villalón CM; Heiligers JP; Saxena PR
    Br J Pharmacol; 1998 Apr; 123(8):1561-70. PubMed ID: 9605562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacology of potent and selective S2-serotonergic antagonists.
    Janssen PA
    J Cardiovasc Pharmacol; 1985; 7 Suppl 7():S2-11. PubMed ID: 2412048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors.
    Tonini M
    Neurogastroenterol Motil; 2005 Oct; 17(5):637-42. PubMed ID: 16185301
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical application of serotonin antagonists in the treatment of hypertension].
    Deguchi F; Saito T; Inagaki Y
    Nihon Rinsho; 1989 Sep; 47(9):2058-63. PubMed ID: 2593279
    [No Abstract]   [Full Text] [Related]  

  • 19. Age and the platelet serotonin vasoconstrictor axis in essential hypertension.
    Amstein R; Fetkovska N; Lüscher TF; Kiowski W; Bühler FR
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S35-40. PubMed ID: 2459512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel.
    Gershon MD
    Aliment Pharmacol Ther; 1999 May; 13 Suppl 2():15-30. PubMed ID: 10429737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.